Cargando…
Strategies to improve the therapeutic effect of pluripotent stem cell-derived cardiomyocytes on myocardial infarction
Myocardial infarction (MI) is a common cardiovascular disease caused by permanent loss of cardiomyocytes and the formation of scar tissue due to myocardial ischemia. Mammalian cardiomyocytes lose their ability to proliferate almost completely in adulthood and are unable to repair the damage caused b...
Autores principales: | Xiao, Yang, Chen, Yihuan, Shao, Chunlai, Wang, Yaning, Hu, Shijun, Lei, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9388750/ https://www.ncbi.nlm.nih.gov/pubmed/35992358 http://dx.doi.org/10.3389/fbioe.2022.973496 |
Ejemplares similares
-
Xenogeneic-Free System for Biomanufacturing of Cardiomyocyte Progeny From Human Pluripotent Stem Cells
por: Ashok, Preeti, et al.
Publicado: (2020) -
Engineering the maturation of stem cell-derived cardiomyocytes
por: Hong, Yi, et al.
Publicado: (2023) -
Vascularization of Engineered Spatially Patterned Myocardial Tissue Derived From Human Pluripotent Stem Cells in vivo
por: Wanjare, Maureen, et al.
Publicado: (2019) -
Bioreactor Suspension Culture: Differentiation and Production of Cardiomyocyte Spheroids From Human Induced Pluripotent Stem Cells
por: Kahn-Krell, Asher, et al.
Publicado: (2021) -
Comparative analysis of the cardiomyocyte differentiation potential of induced pluripotent stem cells reprogrammed from human atrial or ventricular fibroblasts
por: Wang, Lu, et al.
Publicado: (2023)